NEO
$7.96-0.22 (-2.69%)
NeoGenomics, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, a...
Recent News
A Look At Neo Performance Materials (TSX:NEO) Valuation After Recent Share Price Volatility
Business profile and recent share performance Neo Performance Materials (TSX:NEO) has attracted attention after a recent share price move, with the stock down 14.1% over the past day and 22.5% over the past week, despite gains in the past 3 months and year. The company, headquartered in Toronto and founded in 1994, manufactures and sells rare earth, magnetic powders, magnets, and rare metal based functional materials across Asia, North America, Europe, and other international markets. Its...
Is It Too Late To Reassess Neo Performance Materials (TSX:NEO) After Its 1-Year Surge?
If you are wondering whether Neo Performance Materials is still good value after a strong run, the key question is how its current share price compares with what the underlying business may be worth. The stock last closed at $23.84, with returns of 16.0% over 30 days, 41.1% year to date, and 166.8% over 1 year. This naturally raises questions about both upside potential and changing risk perceptions. Recent coverage has focused on Neo Performance Materials as a rare earth and advanced...
Neo Performance Materials Q4 Earnings Call Highlights
Neo Performance Materials (TSE:NEO) highlighted higher profitability and strategic progress during its fourth-quarter 2025 earnings call, pointing to volume growth across key product lines, cost improvements from automation, and continued investment in its European permanent magnet and separation in
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market
NeoGenomics Inc. (NASDAQ:NEO) is one of the most buzzing stocks to buy with the highest upside potential. On February 25, NeoGenomics officially launched RaDaR ST, a tumor-informed circulating tumor DNA/ctDNA assay designed to detect molecular residual disease/MRD across various solid tumor types. This launch targets a rapidly growing MRD market estimated at over $20 billion, […]